Toronto, Canada · Founded 2017 · Privately Held (backing)
Operator of a climate biotech company intended to convert waste into polymers, including polyhydroxyalkanoate bioplastics. Genecis is based in Toronto, Canada and was founded in 2017. Its last reported valuation was $40 million in Jul 2022. It has raised $20 million.
Last reported valuation
$40.0M
Oct 2026
Priced at
—
Total raised
$20.0M
Last round
—
Cap table — not yet on record
Genecis's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Genecis with a free account
·The complete investor list: 48 names
·Watch Genecis: the Monday email on marks, rounds and moves
